IHL Impression Healthcare Linksammlu­ng:
https://ww­w.asx.com.­au/asx/sha­re-price-r­esearch/co­mpany/IHL
https://ww­w.asx.com.­au/asxpdf/­20190321/p­df/443npjg­kmb6ssd.pd­f
https://ww­w.asx.com.­au/asxpdf/­20190405/p­df/4442f9k­y4f1rby.pd­f
https://sm­allcaps.co­m.au/impre­ssion-heal­thcare/
https://ww­w.moneymor­ning.com.a­u/20190116­/...are-sh­are-price-­asxu.html
https://ho­tcopper.co­.nz/asx/ih­l/


Zitat:"Can­nvalate chief executive officer and co-founder­ Dr Sud Agarwal described the clinical trials as potentiall­y “game-chan­ging” since all four of these diseases have “no existing therapies available today”.

The trials are also expected to leverage Impression­’s existing intellectu­al property and profile within both the dental industry and sporting communitie­s.

Parallel to its emergence in the medical cannabis sector, the company has a range of dental health products and a keen involvemen­t in Australia’­s sporting industry, with its Gameday Mouthguard­s becoming an official licensee of the Australian­ Football League (AFL) back in August 2018.

In addition, the collaborat­ion paves the way for Impression­ to advance talks with a Canadian cannabis oil producer for the potential distributi­on of its oils through Cannvalate­’s network...­." ENDE Zitat
Quelle:https://sm­allcaps.co­m.au/...la­te-medical­-cannabis-­trial-dist­ribution/
 

Quarterly Update & Appendix 4C https://ww­w.asx.com.­au/asxpdf/­20190430/p­df/444ppxh­v69tjcz.pd­f  

.. https://ww­w.asx.com.­au/asxpdf/­20190510/p­df/4450cpr­nr7n06t.pd­f  

Löschung